1 “Diabetes Days” A Practice Efficiency Strategy Improving Diabetes Mellitus Patient Care Delivery & Outcomes.
Www.dmscan.ca The DM-SCAN program has been made possible through the support of Merck Canada Inc. The opinions expressed in this material are those of.
Diabetes Care Community - Lipohypertrophy & Injection Techniques
SGLT2 Endocrine CME Grand Rounds Final
The Emerging Role of SGLT Inhibitors in Individualized Treatment of T2DM New Perspectives in Diabetes: New Targets, New Therapies, and a New Approach to.
The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
TYPE 2 DIABETES MELLITUS REVIEW OF Clinical Practice Guidelines WEEK 2: Therapy UHN AIMGP CLINIC SEMINAR SERIES 2007 Updates Dr. K. Tzanetos WEEK 2: Therapy.
Back to Basics: Endocrinology Diabetes, Obesity and Thyroid.
Obesity: prevalence, influences and challenges Canadian Medical Association recognizes obesity as a chronic disease (October 2015).
TYPE 1, TYPE 2, AND GESTATIONAL DIABETES AMONG LATINOS IN NEW YORK Kevin Cabrera & Margie Perez.
Beyond Carbohydrate Counting: What Else Matters? Lorraine Anderson RD, CDE Senior Clinical Manager, Animas Canada 2015 CWD Friends for Life Canada Conference.
Canadian Ophthalmological Society
